Recent news
UKSA calls for independent thinkers to join us to change for the better the savings investment chain.
This may take a generation - too many vested interests, contributing too much in tax revenues, will make it so – but is vital to the long-term economic health and social cohesion of the UK.
I wanted to give you a brief update as to how the campaign for compensation is going (yes, it still is going!).
A shareholder has won a battle to avoid an attempted charge of £25,000 by Capita Registrars to indemnify against the consequences of a lost share certificate.
The certificate had been mailed to Capita so that a small part-sale could be made, the balance certificate had been returned by regular mail and had been lost.
John Hunter, our Chairman, is enormously appreciative of the result of the informal donations appeal
John reports that the informal donations appeal has so far yielded over £1,500. Our thanks to you all. Substantial individual donations are welcome, of course, but equal leverage comes from small amounts spread among large numbers of members. Donations can still be made by credit card or PayPal by clicking on this link.
Harry Braund, Chairman of UKSA London & South East, took part in an interview with Share Radio's Ed Bowsher.
You can hear the interview by clicking here .
A paper by David Pitt-Watson and sponsored by Pension Insurance Corporation,‘The Purpose of Finance’, shines a spotlight on an industry where ‘……many of its activities fail to achieve the purpose that they could and should be pursuing.’
This company was born out of Helphire which hit hard times following the financial crash. It seems to be making good progress now but what business is it really in? Is it a provider of outsourced services to the insurance industry or is it a good old-fashioned car-fleet management business?
The Study's interim conclusions support many of the findings of a report submitted by UKSA to the regulator (then the FSA) five years ago. UKSA's response to the study, together with its report of 2012, can be found here .
This is a fast-growing provider of generic pharmaceutical products. From an investor’s standpoint, however, one would like to hear how the rapid increase in revenues can be turned into increased profitability by increasing Gross Margins – which is likely to mean changing the product mix, putting pressure on suppliers, increasing prices, or a…